Sex and gender differences in the brain cholinergic system and in the response to therapy of alzheimer disease with cholinesterase inhibitors

Current Alzheimer Research

Volumn 15, Issue 11, 2018, Pages 1077-1084

  Giacobini, Ezio ^a   Pepeu, Giancarlo ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acetylcholine; Aging; Cholinesterase inhibitors; Estrogens; Nerve growth factor; Nucleus basalis magnocellularis; Organophosphates

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; BRAIN; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; SEXUAL CHARACTERISTICS;

ACETYLCHOLINE; ALZHEIMER DISEASE; BRAIN; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS;

EID: 85053697649     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205015666180613111504     Document Type: Review

References (69)

1. Counts SE, Che S, Ginsberg SD, Mufson EJ. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer’s disease. J Chem Neuroanat 42: 111-17 (2011).
2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Bre-teler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54(5): S4-9 (2000)
3. Mehta N, Rodrigues C, Lamba M, Wu W, Bronskill SE, Herrmann N, et al. Systematic review of sex-specific reporting of data: cholinesterase inhibitor example. J Am Geriatr Soc 65: 2213-19 (2017).
4. McCarthy MM, Woolley CS, Arnold AP. Incorporating sex as a biological variable in neuroscience: what do we gain? Nat Rev Neurosci 18: 707-08 (2017).
5. Rhodes ME, Rubin RT. Functional sex differences ('sexual dier-gism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res Brain Res Rev 30: 135-52 (1999).
6. Mesulam MM, Mufson EJ, Wainer BH, Levey AI. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185-1201 (1983).
7. Woolf NJ, Butcher LL. Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis. Brain Res Bull 7: 487-507 (1981).
8. Hallanger AE, Wainer BH. Ascending projections from the pedun-culopontine tegmental nucleus and the adjacent mesopontine teg-mentum in the rat. J Comp Neurol 274: 483-15 (1988).
9. Südhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80: 675-90 (2013).
10. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75: 1320-31 (2000).
11. Muramatsu I, Uwada J, Masuoka T, Yoshiki H, Sada K, Lee KS. Regulation of synaptic acetylcholine concentrations by acetylcholine transport in rat striatal cholinergic transmission. J Neurochem1 43: 76-86 (2017).
12. Haywood WM, Mukaetova-Ladinska EB. Sex influences on cholinesterase inhibitor treatment in elderly individual with Alzheimer’s disease. Am J Geriat Pharmacother 4: 273-86 (2006).
13. Mitsushima D. Sex differences in the septo-hippocampal cholinergic system in rats: behavioral consequences. In: Neill JC, Kulkarni J, editors. Biological basis of sex differences in Psychopharma-cology. Curr Top Behav Neurosci 8: 57-71 (2010).
14. Luine VN, Renner KJ, Keady S, Jones KJ. Age and sex-dependent decrease in ChAT in basal forebrain nuclei. Neurobiol Aging 7: 193-98 (1986).
15. Sirviö J, Valjakka A, Jolkkonen J, Hervonen A, Riekkinen PJ. Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex. Comp Biochem Physiol C90(1): 245-8 (1988).
16. Cardoso A, Paula-Barbosa MM, Lukoyanov NV. Reduced density of neuropeptide Y neurons in the somatosensory cortex of old male and female rats: relation to cholinergic depletion and recovery after nerve growth factor treatment. Neuroscience 134: 937-48 (2006).
17. Veng LM, Granholm AC, Rose GM. Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats. Physiol Behav 80: 27-36 (2003).
18. Takase K, Mitsushima D, Funabashi T, Kimura F. Sex differences in the 24-h acetylcholine release profile in the premo-tor/supplementary motor area of behaving rats. Brain Res 1154: 105-15 (2007).
19. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, et al. Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol 24: 33-44 (2014).
20. Schaevitz LR, Berger-Sweeney J. Neurogenesis of the cholinergic medial septum in female and male C57BL/6j mice. J Neurobiol 65: 294-303 (2005).
21. Takase K, Kimura F, Yagami D, Mitsushima D. Sex specific 24-h acetylcholine release profile in the medial prefrontal cortex: simultaneous measurement of spontaneous locomotor activity in behaving rats. Neuroscience 159: 7-15 (2009).
22. Iulita MF, Cuello AC. The NGF, metabolic pathway in the CNS and its dysregulation in Down syndrome and Alzheimer’s disease. Curr Alzheimer Res 13: 53-67 (2016).
23. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gon-floni S, et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy. J. Neurosci 20: 2589-2601 (2000).
24. Kornack DR, Lu B, Black IB. Sexually dimorphic expression of the NGF receptor gene in the developing rat brain. Brain Res 542: 171-4 (1991).
25. Loy R, Sheldon RA. Sexually dimorphic development of cholinergic enzymes in the rat septo-hippocampal system. Brain Res 431: 156-60 (1987).
26. Pondiki S, Stamatakis A, Fragkouli A, Philippidis H, Stylianopou-los F. Effects of neonatal handling on the basal forebrain cholinergic system of adult male and female rats. Neuroscience 142: 305-14 (2006).
27. Hohman CF, Berger-Sweeney J. Sexually dimorphic responses to neonatal basal forebrain lesions in mice: II. Cortical morphology. J Neurobiol 37: 595-606 (1998).
28. Arters J, Hohmann CF, Mills J, Olaghere O, Berger-Sweeney J. Sexually dimorphic responses to neonatal basal forebrain lesions in mice: I. Behavior and neurochemistry. J Neurobiol 37: 582-94 (1998).
29. Pepeu G, Giovannini MG. Changes in acetylcholine extracellular levels during cognitive processes. Learn Mem 11: 21-7 (2004).
30. Gur RC, Gunning-Dixon F, Bilker WB, Gur RE. Sex differences in temporo-limbic and frontal brain volumes of healthy adults. Cereb Cortex 12: 998-1003 (2002).
31. Gur RE, Gur RC. Gender differences in aging: cognition, emotion, and neuroimaging studies. Dialogues Clin Neurosci 4(2): 197-210 (2002).
32. Berger-Sweeney J, Arnold A, Gabeau D, Mills J. Sex differences in learning and memory in mice: effects of sequence of testing and cholinergic blockade. Behav Neurosci 109: 859-73 (1995).
33. Hall BJ, Abreu-Villaça Y, Cauley M, Junaid S, White H, Kiany A, et al. The ventral hippocampal muscarinic cholinergic system plays a key role in sexual dimorphisms of spatial working memory in rats. Neuropharmacology 117: 106-13 (2017).
34. Pepeu G, Giovannelli L. The central cholinergic system during aging. Progr Brain Res 100: 67-71 (1994).
35. Lukoyanov NV, Andrade JP, Dulce Madeira M, Paula-Barbosa MM. Effects of age and sex on water maze performance and hippocampal cholinergic fibers in rats. Neurosci Lett 269: 141-4 (1999).
36. Gibbs RB. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol 151: 289-302 (1998).
37. Alves-Amaral G, Pires-Oliveira M, Andrade-Lopes AL, Chiave-gatti T, Godinho RO. Gender-related differences in circadian rhythm of rat plasma acetyl-and butyryl-cholinesterase: effects of sex hormone withdrawal. Chem Biol Interact 7: 186: 9-15 (2010).
38. Wang RH, Bejar C, Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39: 497-506 (2000).
39. Buccafusco JJ, Jackson WJ, Stone JD, Terry AV. Sex dimorphisms in the cognitive-enhancing action of the Alzheimer’s drug donepezil in aged Rhesus monkeys. Neuropharmacology 44: 381-99 (2003).
40. Smith CD, Wright LK, Garcia GE, Lee RB, Lumley LA. Hormone-dependence of sarin lethality in rats: sex differences and stage of the estrous cycle. Toxicol Appl Pharmacol 287: 253-7 (2015).
41. Smolen TN, Han PC, Collins AC. Sex differences in the recovery of brain acetylcholinesterase activity following a single exposure to DFP. Pharmacol Biochem Behav 26(4): 813-20 (1987).
42. Comfort N, Re DB. Sex-Specific neurotoxic effects of organophosphate pesticides across the life course. Curr Environ Health Rep 4: 392-404 (2017).
43. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89: 4668-72 (1992).
44. Miller MM, Hyder SM, Assayag R, Panarella SR, Tousignant P, Franklin KB. Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience 91: 1143-53 (1999).
45. Bora SH, Liu Z, Kecojevic A, Merchenthaler I, Koliatsos VE. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Exp Neurol 194: 506-22 (2005).
46. Milne MR, Haug CA, Abraham IM, Kwakowsky A. Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo. Endocrinology 156: 623-26 (2015).
47. Gibbs RB. Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann NY Acad Sci 743: 165-96 (1994).
48. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484-90 (1985).
49. Gibbs RB, Hashash A, Johnson DA. Effects of estrogen on potas-sium-evoked acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res 749: 143-6 (1997).
50. Nakamura N, Fujitab H, Kawata M. Effects of gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats. Neuroscience 109: 473-8 (2002).
51. Granholm AC, Ford KA, Hyde LA, Bimonte HA, Hunter CL, Nelson M, et al. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiol Behav 77: 371-85 (2002).
52. Gibbs RB, Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 34: 98-111 (1998).
53. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giaco-bini E, Jones R, et al. Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014. J Intern Med 275: 251-83 (2014).
54. Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, et al. Apolipoprotein E genotype and sex risk factors for Alzheimer’s disease-a meta-analysis. JAMA Neurol 74: 1178-89 (2017).
55. Payami H, Montee KR, Kaye JA, Bird TD, Yu CE, Wijsman EM, et al. Alzheimer’s disease apolipoprotein E4, and gender. JAMA 271: 1316-17 (1994).
56. Farrer LA, Cupples LA, van Duijn CM, Kurz A, Zimmer R, Müller U, et al. Apolipoprotein E genotype in patients with Alzheimer’s disease: implications for the risk of dementia among relatives. Ann Neurol 38: 797-808 (1995).
57. Ungar L, Altmann A, Greicius MD. Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction. Brain Imaging Behav 8: 262-73 (2014).
58. Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer’s disease. Neurology 50: 669-77 (1998).
59. Venerosi A, Ricceri L, Tait S, Calamandrei G. Sex dimorphic be-haviors as markers of neuroendocrine disruption by environmental chemicals: the case of chlorpyrifos. Neurotoxicology 33: 1420-26 (2012).
60. De Felice A, Venerosi A, Ricceri L, Sabbioni M, Scattoni ML, Chiarotti F, et al. Sex-dimorphic effects of gestational exposure to the organophosphate insecticide chlorpyrifos on social investigation in mice. Neurotoxicol Teratol 46: 32-9 (2014).
61. Suarez-Lopez JR, Himes JH, Jacobs DR Jr, Alexander BH, Gunnar MR. Acetylcholinesterase activity and neurodevelopment in boys and girls. Pediatrics 132: e1649-58 (2013).
62. González-Alzaga B, Lacasana M, Aguilar-Garduno C, Rodriguez-Barranco M, Ballester F, Rebagliato M, et al. A systematic review of neurodevelopmental effects of prenatal and postnatal organophosphate pesticide exposure. Toxicol Lett 230: 104-21 (2014).
63. Miller CS, Mitzel HC. Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health 50: 119-29 (1995).
64. Canevelli M, Quarata F, Remiddi F, Lucchini F, Lacorte E, Vana-core N, et al. Sex and gender differences in the treatment of Alzheimer’s disease: a systematic review of randomized controlled trials. Pharmacol Res 115: 218-23 (2016).
65. Ferris S, Lane R, Sfikas N, Winblad B, Farlow M, Feldman HH. Effects of gender on response to treatment with rivastigmine in mild cognitive impairment. A post-statistical modeling ap-proach.Gend Med 6: 345-55 (2009).
66. Wattmo C, Londos E, Minthon L. Risk factors that affect life expectancy in Alzheimer’s disease: a 15-year follow-up. Dement Geriatr Cogn Disord 38: 286-99 (2014).
67. Scacchi R, Gambina G, Broggio E, Corbo RM. Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 29: 610-15 (2014).
68. Wattmo C, Wallin AK, Londos E, Minthon L. Predictors of long-term cognitive outcome in Alzheimer’s disease. Alzheimers Res Ther 3(4): 23 (2011).
69. Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer’s disease. Alzheimers Res Ther 2: 2 (2010).